CTi Biopharma Corp Volatility
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
We have found twenty-four technical indicators for CTi Biopharma Corp, which you can use to evaluate the volatility of the firm. Please confirm CTi Biopharma's Downside Deviation of 2.35, risk adjusted performance of 0.0967, and Mean Deviation of 3.53 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to CTi Biopharma's volatility include:
720 Days Market Risk | Chance Of Distress | 720 Days Economic Sensitivity |
CTi Biopharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of CTi daily returns, and it is calculated using variance and standard deviation. We also use CTi's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of CTi Biopharma volatility.
CTi |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as CTi Biopharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of CTi Biopharma at lower prices. For example, an investor can purchase CTi stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of CTi Biopharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with CTi Stock
| 0.63 | CVI | CVR Energy Financial Report 6th of May 2024 | PairCorr |
| 0.84 | CE | Celanese Financial Report 14th of May 2024 | PairCorr |
| 0.86 | MDH | MDH Acquisition Corp | PairCorr |
Moving against CTi Stock
| 0.84 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.59 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
| 0.52 | TRCA | Twin Ridge Capital | PairCorr |
| 0.5 | LION | Lionheart III Corp | PairCorr |
CTi Biopharma Market Sensitivity And Downside Risk
CTi Biopharma's beta coefficient measures the volatility of CTi stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents CTi stock's returns against your selected market. In other words, CTi Biopharma's beta of -1.28 provides an investor with an approximation of how much risk CTi Biopharma stock can potentially add to one of your existing portfolios. CTi Biopharma Corp is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CTi Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CTi Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze CTi Biopharma Corp Demand TrendCheck current 90 days CTi Biopharma correlation with market (NYSE Composite)CTi Beta |
CTi standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by CTi Biopharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of CTi Biopharma's daily returns or price. Since the actual investment returns on holding a position in cti stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in CTi Biopharma.
CTi Biopharma Corp Stock Volatility Analysis
Volatility refers to the frequency at which CTi Biopharma delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with CTi Biopharma's price changes. Investors will then calculate the volatility of CTi Biopharma's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of CTi Biopharma's volatility:
Historical Volatility
This type of delisted stock volatility measures CTi Biopharma's fluctuations based on previous trends. It's commonly used to predict CTi Biopharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for CTi Biopharma's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on CTi Biopharma's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
CTi Biopharma Projected Return Density Against Market
Given the investment horizon of 90 days CTi Biopharma Corp has a beta of -1.2829 suggesting as returns on its benchmark rise, returns on holding CTi Biopharma Corp are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, CTi Biopharma is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CTi Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CTi Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CTi delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
CTi Biopharma Corp has an alpha of 1.5912, implying that it can generate a 1.59 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a CTi Biopharma Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.CTi Biopharma Stock Return Volatility
CTi Biopharma historical daily return volatility represents how much of CTi Biopharma delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6179% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About CTi Biopharma Volatility
Volatility is a rate at which the price of CTi Biopharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of CTi Biopharma may increase or decrease. In other words, similar to CTi's beta indicator, it measures the risk of CTi Biopharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of CTi Biopharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. Cti Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 121 people.
CTi Biopharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on CTi Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much CTi Biopharma's price varies over time.
3 ways to utilize CTi Biopharma's volatility to invest better
Higher CTi Biopharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of CTi Biopharma Corp stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. CTi Biopharma Corp stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of CTi Biopharma Corp investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in CTi Biopharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of CTi Biopharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
CTi Biopharma Investment Opportunity
NYSE Composite has a standard deviation of returns of 0.62 and is 9.223372036854776E16 times more volatile than CTi Biopharma Corp. 0 percent of all equities and portfolios are less risky than CTi Biopharma. You can use CTi Biopharma Corp to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of CTi Biopharma to be traded at $9.0 in 90 days.Good diversification
The correlation between CTi Biopharma Corp and NYA is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and NYA in the same portfolio, assuming nothing else is changed.
CTi Biopharma Additional Risk Indicators
The analysis of CTi Biopharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in CTi Biopharma's investment and either accepting that risk or mitigating it. Along with some common measures of CTi Biopharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0967 | |||
| Market Risk Adjusted Performance | (1.17) | |||
| Mean Deviation | 3.53 | |||
| Semi Deviation | 0.9064 | |||
| Downside Deviation | 2.35 | |||
| Coefficient Of Variation | 707.98 | |||
| Standard Deviation | 10.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
CTi Biopharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
| Alphabet vs. CTi Biopharma | ||
| Citigroup vs. CTi Biopharma | ||
| Microsoft vs. CTi Biopharma | ||
| Ford vs. CTi Biopharma | ||
| Visa vs. CTi Biopharma | ||
| Salesforce vs. CTi Biopharma | ||
| Walker Dunlop vs. CTi Biopharma | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against CTi Biopharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. CTi Biopharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, CTi Biopharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to CTi Biopharma Corp.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |